MAPT and Alzheimer disease: Further, the trajectory of an individual’s brain network composition over time, as measured by fMRI, has been shown to be independent of AD–related genetic risk factors (APOE status), AD–related pathology (cerebrospinal fluid phosphorylated tau, and cortical amyloid), and cortical thinning.